DOCSLIB.ORG

A Tunable Brake for HECT Ubiquitin Ligases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Tunable Brake for HECT Ubiquitin Ligases Article A Tunable Brake for HECT Ubiquitin Ligases Graphical Abstract Authors Zan Chen, Hanjie Jiang, Wei Xu, ..., L. Mario Amzel, Sandra B. Gabelli, Philip A. Cole Correspondence [email protected] (S.B.G.), [email protected] (P.A.C.) In Brief Chen et al. describe an autoinhibitory Phosphorylation mechanism for WWP2, WWP1, ITCH, and NEDD4-1 ubiquitin ligases involving a linker-HECT domain interaction. This intramolecular interaction traps the HECT Autoinhibited HECT Activated HECT enzyme in its inactive state and can be • Blocked allosteric • Moderate activation: relieved by linker phosphorylation. ubiquitin binding site Substrate ubiquitination • Locked hinge loop • Hyper-activation Self-destruction Highlights d Autoinhibition of HECT ubiquitin ligases by a linker segment d Phosphorylation of linker or cancer associated mutation relieves autoinhibition d Complete loss of linker leads to hyperactivation and self- destruction of ligase Chen et al., 2017, Molecular Cell 66, 345–357 May 4, 2017 ª 2017 Elsevier Inc. http://dx.doi.org/10.1016/j.molcel.2017.03.020 Molecular Cell Article A Tunable Brake for HECT Ubiquitin Ligases Zan Chen,1 Hanjie Jiang,1 Wei Xu,1 Xiaoguang Li,2 Daniel R. Dempsey,1 Xiangbin Zhang,3 Peter Devreotes,2 Cynthia Wolberger,3,5 L. Mario Amzel,3,5 Sandra B. Gabelli,3,4,5,* and Philip A. Cole1,5,6,* 1Department of Pharmacology and Molecular Sciences 2Department of Cell Biology 3Department of Biophysics and Biophysical Chemistry 4Department of Medicine 5Department of Oncology John Hopkins School of Medicine, Baltimore, MD 21205, USA 6Lead Contact *Correspondence: [email protected] (S.B.G.), [email protected] (P.A.C.) http://dx.doi.org/10.1016/j.molcel.2017.03.020 SUMMARY Of the 28 human HECT domain E3 ligases, the most intensively studied comprise the nine members of the NEDD4 family (Fig- The HECT E3 ligases ubiquitinate numerous tran- ure S1A) (Bernassola et al., 2008; Buetow and Huang, 2016; scription factors and signaling molecules, and their Scheffner and Kumar, 2014). Members of the NEDD4 family activity must be tightly controlled to prevent cancer, include WWP2, WWP1, ITCH, and NEDD4-1, and these E3 immune disorders, and other diseases. In this study, ligases target for destruction key signaling molecules and tran- we have found unexpectedly that peptide linkers scription factors (Aki et al., 2015; Buetow and Huang, 2016; tethering WW domains in several HECT family mem- Chen et al., 2014; Scheffner and Kumar, 2014; Zhi and Chen, 2012). Abnormal activities of NEDD4 E3 ligases are connected bers are key regulatory elements of their catalytic ac- to cancer, immune disorders, and other diseases (Aki et al., tivities. Biochemical, structural, and cellular analyses 2015; Broix et al., 2016; Buetow and Huang, 2016; Chen et al., have revealed that the linkers can lock the HECT 2014; Scheffner and Kumar, 2014; Zhi and Chen, 2012). The domain in an inactive conformation and block the NEDD4 family proteins each contain an N-terminal C2 domain proposed allosteric ubiquitin binding site. Such followed by two to four WW domains and culminate in a C-termi- linker-mediated autoinhibition of the HECT domain nal catalytic HECT domain (Figures 1A and S1A) (Buetow and can be relieved by linker post-translational modifica- Huang, 2016). The C2 and WW domains have been implicated tions, but complete removal of the brake can induce in substrate selectivity and catalytic regulation of NEDD4 E3 hyperactive autoubiquitination and E3 self destruc- ligases (Bruce et al., 2008; Escobedo et al., 2014; Mari et al., tion. These results clarify the mechanisms of several 2014; Riling et al., 2015; Wiesner et al., 2007). HECT protein cancer associated mutations and pro- Prior structural studies have revealed that HECT domains contain a larger N-lobe which can interact with E2 proteins and vide a new framework for understanding how HECT a smaller C-lobe that contains a catalytic Cys residue involved ubiquitin ligases must be finely tuned to ensure in ubiquitin transfer (Buetow and Huang, 2016). In addition, normal cellular behavior. several HECT family members have been shown to possess an N-lobe ubiquitin binding exosite (Kim et al., 2011; Maspero et al., 2011; Zhang et al., 2016). Remote from the ubiquitin sub- INTRODUCTION strate binding site in the HECT C-lobe, this exosite has been characterized structurally and shown to engage a distinct ubiq- HECT domain ubiquitin transferases (E3 ligases) catalyze the Lys uitin molecule in HECTs, and this can catalytically activate these ubiquitination of numerous cellular proteins and are critical for E3 ligases (Kim et al., 2011; Maspero et al., 2011, 2013; Ogunjimi protein homeostasis and cell signaling (Buetow and Huang, et al., 2010; Zhang et al., 2016). The N- and C-lobes are con- 2016; Scheffner and Kumar, 2014). Like all E3 ligases, HECT en- nected by a hinge loop, and the HECT domains have been zymes are activated by the participation of upstream E1 and E2 captured in two conformational states, a ground state T-shape enzymes. In contrast to the RING family of E3 ligases, which have (Maspero et al., 2011; Verdecia et al., 2003) and a catalytically an indirect role in ubiquitin bond formation, HECT domains have proficient L-shape (Kamadurai et al., 2013; Maspero et al., an active site Cys that is charged with ubiquitin by the E2. The 2011). The dynamic interconversion of the T-shape and L-shape HECT thioester intermediate directly ubiquitinates target pro- HECT conformations is necessary for turnover, but what governs teins and itself on Lys residues. Because of their direct role in this transition is uncertain. Interactions with the C2 domain, WW catalysis, it is presumed that HECT E3 ligases must be held in domains, and various post-translational modifications have check to prevent both excessive target ubiquitination, as well each been proposed to influence HECT domain catalytic activity, as self-destruction by autoubiquitination (Broix et al., 2016; Bue- but biochemical details for this have generally been lacking tow and Huang, 2016). (Bruce et al., 2008; Gallagher et al., 2006; Gao et al., 2004; Molecular Cell 66, 345–357, May 4, 2017 ª 2017 Elsevier Inc. 345 Figure 1. Full-Length WWP2 Is Autoinhibited (A) Schematic of WWP2 domains with amino acid residue numbers. (B) Ubiquitination assay of GST-tagged WWP2 and GST-free WWP2. The reaction was conducted at 30 C in the presence of 5 mM MgCl2, 5 mM ATP, 100 mM wild-type ubiquitin, 50 nM E1, 1 mM E2 (UbcH5c), and 1 mM E3. The reaction was quenched at 0, 0.5, and 2 hr and samples analyzed by SDS-PAGE followed by colloidal blue staining. The activity of WWP2 was determined by the time-dependent depletion of the unmodified E3 ligase band and the appearance of higher MW bands presumed to represent poly-ubiquitination. (C) Ubiquitination assay of GST-WWP2, full-length WWP2 (FL-WWP2), and WWP2 DC2. The reaction was conducted in the same condition as Figure 1B and quenched at the times indicated. (D) Schematic diagram showing that a TEV protease cleavage site (ENLYFQ/G) was inserted by mutagenesis between residues Ser395 and Ala396 just N-terminal to the WW3 domain. This purified TEV-site containing WWP2 protein was cleaved by TEV protease into a N-terminal fragment X containing the C2 domain, the WW1 domain, and the WW2 domain and a C-terminal fragment Y containing the WW3 domain, the WW4 domain, and the HECT domain. (E) Size-exclusion chromatogram of the TEV-cleaved WWP2 (solid line trace) superimposed with MW standards (dashed line trace). There were two major peaks, Peak A (100 kDa) and Peak B (50 kDa). (legend continued on next page) 346 Molecular Cell 66, 345–357, May 4, 2017 Persaud et al., 2014; Riling et al., 2015; Scheffner and Kumar, importance of WW domain engagement in WWP2 catalytic 2014; Wiesner et al., 2007; Yang et al., 2006). regulation. Here, we investigate the regulation of WWP2, a NEDD4 family We next introduced a protease site N-terminal to the WW3 member that has been shown to ubiquitinate and target for domain in WWP2 (Figure 1D) and determined that the WW3- removal the key tumor suppressor PTEN and the important WW4-HECT protein fragment could partially co-elute with the stem cell-related transcription factor OCT4 (Maddika et al., C2-WW1-WW2 fragment by size exclusion chromatography 2011; Xu et al., 2009). WWP2 contains four WW domains (Figures 1E and 1F). This raised the possibility that interactions (WW1–WW4) and is most closely related to the NEDD4 family between the N-terminal and C-terminal components of WWP2 members WWP1 and ITCH, which have been linked to cancer might modulate the activity of intact full-length WWP2. Consis- and immunologic control (Bernassola et al., 2008; Chang et al., tent with this hypothesis, purified recombinant WWP2 HECT 2006; Zhi and Chen, 2012). Our studies have revealed an unan- domain and WW3-WW4-HECT protein showed robust autoubi- ticipated autoinhibitory module centrally located in WWP2, quitination activity (Figure 1G). Based on these findings, we sus- WWP1, and ITCH between the WW2 and WW3 domains, and pected that the WW1-WW2 moiety was crucial for enforcing below we describe the mechanism of this regulation and its autoinhibition of WWP2. However, intermolecular addition of a general significance in the NEDD4 family. purified recombinant WW1-WW2 protein fragment to WW3- WW4-HECT WWP2 did not inhibit the latter’s ubiquitin trans- RESULTS ferase activity (Figure S2C). WWP2 E3 Ligase Activity Is Autoinhibited The WW2-WW3 Linker, 2,3-Linker, as an Autoinhibitory In the course of in vitro analysis of full-length WWP2 and ubiq- Module of WWP2 uitination of its protein substrate PTEN (Chen et al., 2016), we Because of the lack of an apparent role for the C2 or WW observed that the fusion protein glutathione S-transferase- domains in WWP2 catalytic regulation, we considered the possi- WWP2 (GST-WWP2) was a robust catalyst (Figures 1Band bility that the 30 amino acid (aa) WW2-WW3 linker (2,3-linker), S1B).
Load more

Recommended publications
  • The Nedd4 Family of E3 Ubiquitin Ligases: Functional Diversity Within a Common Modular Architecture
    Oncogene (2004) 23, 1972–1984 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $25.00 www.nature.com/onc The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture Robert J Ingham*,1, Gerald Gish1 and Tony Pawson1,2 1Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada M5G 1X5; 2Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8 Neuronal precursor cell-expressed developmentally down- Nedd4 was originally identified in 1992, in a screen for regulated 4 (Nedd4)is the prototypical protein in a family genes developmentally downregulated in the early of E3 ubiquitin ligases that have a common domain embryonic mouse central nervous system (Kumar et al., architecture. They are comprised of a catalytic C-terminal 1992), and resembles other regulatory proteins in HECT domain and N-terminal C2 domain and WW containing multiple, distinct modular domains (Pawson domains responsible for cellular localization and substrate and Nash, 2003). Subsequently, related proteins with recognition. These proteins are found throughout eukar- similar structures have been characterized. All contain a yotes and regulate diverse biological processes through the catalytic HECT domain at the C-terminus, and an N- targeted degradation of proteins that generally have a terminal region involved in substrate recognition, that PPxY motif for WW domain recognition, and are found includes a C2 domain and a series of WW domains. in the nucleus and at the plasma membrane. Whereas the Although the common modular architecture of the yeast Saccharomyces cerevisiae uses a single protein, Nedd4 family might suggest a redundant functional role Rsp5p, to carry out these functions, evolution has provided for these proteins, recent work has begun to define higher eukaryotes with several related Nedd4 proteins that specific cellular activities for individual members, and to appear to have specialized roles.
    [Show full text]
  • Degradation and Beyond: Control of Androgen Receptor Activity by the Proteasome System
    CELLULAR & MOLECULAR BIOLOGY LETTERS Volume 11, (2006) pp 109 – 131 http://www.cmbl.org.pl DOI: 10.2478/s11658-006-0011-9 Received: 06 December 2005 Revised form accepted: 31 January 2006 © 2006 by the University of Wrocław, Poland DEGRADATION AND BEYOND: CONTROL OF ANDROGEN RECEPTOR ACTIVITY BY THE PROTEASOME SYSTEM TOMASZ JAWORSKI Department of Cellular Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland Abstract: The androgen receptor (AR) is a transcription factor belonging to the family of nuclear receptors which mediates the action of androgens in the development of urogenital structures. AR expression is regulated post- * Corresponding author: e-mail: [email protected] Abbreviations used: AATF – apoptosis antagonizing factor; APIS complex – AAA proteins independent of 20S; ARA54 – AR-associated protein 54; ARA70 – AR-associated protein 70; ARE – androgen responsive element; ARNIP – AR N-terminal interacting protein; bFGF – basic fibroblast growth factor; CARM1 – coactivator-associated arginine methyltransferase 1; CHIP – C-terminus Hsp70 interacting protein; DBD – DNA binding domain; E6-AP – E6-associated protein; GRIP-1 – glucocorticoid receptor interacting protein 1; GSK3β – glycogen synthase kinase 3β; HDAC1 – histone deacetylase 1; HECT – homologous to the E6-AP C-terminus; HEK293 – human embryonal kidney cell line; HepG2 – human hepatoma cell line; Hsp90 – heat shock protein 90; IGF-1 – insulin-like growth factor 1; IL-6 – interleukin 6; KLK2 –
    [Show full text]
  • View Open Access HPV E6, E6AP and Cervical Cancer Sylvie Beaudenon1 and Jon M Huibregtse*2
    BMC Biochemistry BioMed Central Review Open Access HPV E6, E6AP and cervical cancer Sylvie Beaudenon1 and Jon M Huibregtse*2 Address: 1Asuragen, Inc., 2150 Woodward, Austin, TX 78744, USA and 2Molecular Genetics and Microbiology, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA Email: Jon M Huibregtse* - [email protected] * Corresponding author Published: 21 October 2008 <supplement> <title> <p>Ubiquitin-Proteasome System in Disease Part 2</p> </title> <editor>John Mayer and Rob Layfield</editor> <note>Reviews</note> </supplement> BMC Biochemistry 2008, 9(Suppl 1):S4 doi:10.1186/1471-2091-9-S1-S4 This article is available from: http://www.biomedcentral.com/1471-2091/9/S1/S4 © 2008 Beaudenon and Huibregtse; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Every year, approximately 470,000 new cases of cervical cancer are diagnosed and approximately 230,000 women worldwide die of the disease, with the majority (~80%) of these cases and deaths occurring in developing countries. Human papillomaviruses (HPVs) are the etiological agents in nearly all cases (99.7%) of cervical cancer, and the HPV E6 protein is one of two viral oncoproteins that is expressed in virtually all HPV-positive cancers. E6 hijacks a cellular ubiquitin ligase, E6AP, resulting in the ubiquitylation and degradation of the p53 tumor suppressor, as well as several other cellular proteins.
    [Show full text]
  • Regulation of P53 Localization and Transcription by the HECT Domain E3 Ligase WWP1
    Oncogene (2007) 26, 1477–1483 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc SHORT COMMUNICATION Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1 A Laine and Z Ronai Signal Transduction Program, The Burnham Institute for Medical Research, La Jolla, CA, USA As a key cellular regulatory protein p53 is subject to tight 2003; Doran et al., 2004; Shmueli and Oren, 2005; regulation by several E3 ligases. Here, we demonstrate the Harris and Levine, 2005). Common to these ligases is role of HECT domain E3 ligase, WWP1, in regulating p53 their role in limiting p53 stability and activity. In localization and activity. WWP1 associates withp53 and searching for protein ligases with different effects on p53 induces p53 ubiquitylation. Unlike other E3 ligases, activity, we identified the HECT domain E3 ligase WWP1 increases p53 stability; inhibition of WWP1 WWP1, whose interaction with p53 increases its stability expression or expression of a ligase-mutant form results while reducing its transcriptional activity. in decreased p53 expression. WWP1-mediated stabilization WW domain-containing protein 1 (WWP1) was first of p53 is associated withincreased accumulation of p53 in identified as a novelprotein based on its WW modules– cytoplasm witha concomitant decrease in its transcrip- a 35–40 amino-acid (aa) region exhibiting high affinity tional activities. WWP1 effects are independent of Mdm2 towards the PY motif, a proline-rich sequence followed as they are seen in cells lacking Mdm2 expression. by a tyrosine residue (Verdecia et al., 2003). WWP1 Whereas WWP1 limits p53 activity, p53 reduces expres- shares a characteristic domain organization with the E3 sion of WWP1, pointing to a possible feedback loop ligases Nedd4 and Smurfs, which consists of a C2 mechanism.
    [Show full text]
  • Role of Ubiquitin and the HPV E6 Oncoprotein in E6AP- Mediated Ubiquitination
    Role of ubiquitin and the HPV E6 oncoprotein in E6AP- mediated ubiquitination Franziska Mortensena,b, Daniel Schneidera,c, Tanja Barbica, Anna Sladewska-Marquardta, Simone Kühnlea,1, Andreas Marxb,c, and Martin Scheffnera,b,2 aDepartment of Biology, University of Konstanz, 78457 Konstanz, Germany; bKonstanz Research School Chemical Biology, University of Konstanz, 78457 Konstanz, Germany; and cDepartment of Chemistry, University of Konstanz, 78457 Konstanz, Germany Edited by Aaron Ciechanover, Technion-Israel Institute of Technology, Bat Galim, Haifa, Israel, and approved July 7, 2015 (received for review March 25, 2015) Deregulation of the ubiquitin ligase E6 associated protein (E6AP) autism spectrum disorders (15, 16) and (ii) in mice, results in encoded by the UBE3A gene has been associated with three dif- increased E6AP levels and autistic phenotypes (17). ferent clinical pictures. Hijacking of E6AP by the E6 oncoprotein of The notion that alteration of the substrate spectrum, loss of distinct human papillomaviruses (HPV) contributes to the develop- E3 function, and increased E3 function of E6AP contribute to ment of cervical cancer, whereas loss of E6AP expression or func- the development of distinct disorders indicates that expression tion is the cause of Angelman syndrome, a neurodevelopmental and/or E3 activity of E6AP have to be tightly controlled. Whereas disorder, and increased expression of E6AP has been involved in some mechanisms controlling transcription of the UBE3A gene autism spectrum disorders. Although these observations indicate have been identified (e.g., the paternal allele is silenced by a that the activity of E6AP has to be tightly controlled, only little is UBE3A antisense transcript) (14, 18), only little is known about known about how E6AP is regulated at the posttranslational level.
    [Show full text]
  • Limiting the Power of P53 Through the Ubiquitin Proteasome Pathway
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Limiting the power of p53 through the ubiquitin proteasome pathway Vinod Pant and Guillermina Lozano Department of Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA The ubiquitin proteasome pathway is critical in restrain- Modification of p53 by ubiquitination and deubiquitina- ing the activities of the p53 tumor suppressor. Numerous tion is an important reversible mechanism that effectively E3 and E4 ligases regulate p53 levels. Additionally, regulates its functions (for reviews, see Jain and Barton deubquitinating enzymes that modify p53 directly or 2010; Brooks and Gu 2011; Love and Grossman 2012; indirectly also impact p53 function. When alterations of Hock and Vousden 2014). Mono- or polyubiquitination these proteins result in increased p53 activity, cells arrest of p53 by different E3 ligases regulates its nuclear ex- in the cell cycle, senesce, or apoptose. On the other hand, port, mitochondrial translocation, protein stability, and alterations that result in decreased p53 levels yield transcriptional activity. Another set of enzymes called tumor-prone phenotypes. This review focuses on the deubiquitinases (DUBs) can reverse these effects. Here, physiological relevance of these important regulators of we focus on ubiquitination as a mechanism for regulating p53 and their therapeutic implications. p53 stability and function and review current findings from in vivo models that evaluate the importance of the ubiquitin proteasome system in regulating p53. The p53 tumor suppressor maintains genomic integrity by primarily functioning as a sequence-specific DNA-binding Ubiquitination is critical for regulating p53 transcription factor (Vousden and Prives 2009).
    [Show full text]
  • Regulating the Human HECT E3 Ligases
    Cellular and Molecular Life Sciences (2018) 75:3121–3141 https://doi.org/10.1007/s00018-018-2848-2 Cellular andMolecular Life Sciences REVIEW Regulating the human HECT E3 ligases Jasper Sluimer1 · Ben Distel1,2 Received: 25 February 2018 / Revised: 23 May 2018 / Accepted: 28 May 2018 / Published online: 1 June 2018 © The Author(s) 2018 Abstract Ubiquitination, the covalent attachment of ubiquitin to proteins, by E3 ligases of the HECT (homologous to E6AP C ter- minus) family is critical in controlling diverse physiological pathways. Stringent control of HECT E3 ligase activity and substrate specifcity is essential for cellular health, whereas deregulation of HECT E3s plays a prominent role in disease. The cell employs a wide variety of regulatory mechanisms to control HECT E3 activity and substrate specifcity. Here, we summarize the current understanding of these regulatory mechanisms that control HECT E3 function. Substrate specifcity is generally determined by interactions of adaptor proteins with domains in the N-terminal extensions of HECT E3 ligases. These N-terminal domains have also been found to interact with the HECT domain, resulting in the formation of inhibi- tory conformations. In addition, catalytic activity of the HECT domain is commonly regulated at the level of E2 recruit- ment and through HECT E3 oligomerization. The previously mentioned regulatory mechanisms can be controlled through protein–protein interactions, post-translational modifcations, the binding of calcium ions, and more. Functional activity is determined not only by substrate recruitment and catalytic activity, but also by the type of ubiquitin polymers catalyzed to the substrate. While this is often determined by the specifc HECT member, recent studies demonstrate that HECT E3s can be modulated to alter the type of ubiquitin polymers they catalyze.
    [Show full text]
  • Regulating the Human HECT E3 Ligases
    Cellular and Molecular Life Sciences https://doi.org/10.1007/s00018-018-2848-2 Cellular andMolecular Life Sciences REVIEW Regulating the human HECT E3 ligases Jasper Sluimer1 · Ben Distel1,2 Received: 25 February 2018 / Revised: 23 May 2018 / Accepted: 28 May 2018 © The Author(s) 2018 Abstract Ubiquitination, the covalent attachment of ubiquitin to proteins, by E3 ligases of the HECT (homologous to E6AP C ter- minus) family is critical in controlling diverse physiological pathways. Stringent control of HECT E3 ligase activity and substrate specifcity is essential for cellular health, whereas deregulation of HECT E3s plays a prominent role in disease. The cell employs a wide variety of regulatory mechanisms to control HECT E3 activity and substrate specifcity. Here, we summarize the current understanding of these regulatory mechanisms that control HECT E3 function. Substrate specifcity is generally determined by interactions of adaptor proteins with domains in the N-terminal extensions of HECT E3 ligases. These N-terminal domains have also been found to interact with the HECT domain, resulting in the formation of inhibi- tory conformations. In addition, catalytic activity of the HECT domain is commonly regulated at the level of E2 recruit- ment and through HECT E3 oligomerization. The previously mentioned regulatory mechanisms can be controlled through protein–protein interactions, post-translational modifcations, the binding of calcium ions, and more. Functional activity is determined not only by substrate recruitment and catalytic activity, but also by the type of ubiquitin polymers catalyzed to the substrate. While this is often determined by the specifc HECT member, recent studies demonstrate that HECT E3s can be modulated to alter the type of ubiquitin polymers they catalyze.
    [Show full text]
  • Ubiquitination of E3 Ligases: Self-Regulation of the Ubiquitin System Via Proteolytic and Non-Proteolytic Mechanisms
    Cell Death and Differentiation (2011) 18, 1393–1402 & 2011 Macmillan Publishers Limited All rights reserved 1350-9047/11 www.nature.com/cdd Review Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms P de Bie*,1 and A Ciechanover1 Ubiquitin modification of many cellular proteins targets them for proteasomal degradation, but in addition can also serve non-proteolytic functions. Over the last years, a significant progress has been made in our understanding of how modification of the substrates of the ubiquitin system is regulated. However, little is known on how the ubiquitin system that is comprised of B1500 components is regulated. Here, we discuss how the biggest subfamily within the system, that of the E3 ubiquitin ligases that endow the system with its high specificity towards the numerous substrates, is regulated and in particular via self-regulation mediated by ubiquitin modification. Ligases can be targeted for degradation in a self-catalyzed manner, or through modification mediated by an external ligase(s). In addition, non-proteolytic functions of self-ubiquitination, for example activation of the ligase, of E3s are discussed. Cell Death and Differentiation (2011) 18, 1393–1402; doi:10.1038/cdd.2011.16; published online 4 March 2011 One of the major roles of the covalent modification of cellular to which ubiquitin binds prior to its transfer to the substrate proteins by ubiquitin is signaling them for proteasomal (Figure 1). There are B600 RING finger and B30 HECT degradation (Figure 1). The first step of the modification ligases in humans. Smaller families of ligases (U-box, plant is catalyzed by the ubiquitin-activating enzyme, E1, which homology domain, and zinc finger) have also been described.
    [Show full text]
  • Regulation of the P53 Family Proteins by the Ubiquitin Proteasomal Pathway
    International Journal of Molecular Sciences Review Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway Scott Bang, Sandeep Kaur and Manabu Kurokawa * Department of Biological Sciences, Kent State University, Kent, OH 44242, USA; [email protected] (S.B.); [email protected] (S.K.) * Correspondence: [email protected]; Tel.: +1-330-672-2979 Received: 27 November 2019; Accepted: 24 December 2019; Published: 30 December 2019 Abstract: The tumor suppressor p53 and its homologues, p63 and p73, play a pivotal role in the regulation of the DNA damage response, cellular homeostasis, development, aging, and metabolism. A number of mouse studies have shown that a genetic defect in the p53 family could lead to spontaneous tumor development, embryonic lethality, or severe tissue abnormality, indicating that the activity of the p53 family must be tightly regulated to maintain normal cellular functions. While the p53 family members are regulated at the level of gene expression as well as post-translational modification, they are also controlled at the level of protein stability through the ubiquitin proteasomal pathway. Over the last 20 years, many ubiquitin E3 ligases have been discovered that directly promote protein degradation of p53, p63, and p73 in vitro and in vivo. Here, we provide an overview of such E3 ligases and discuss their roles and functions. Keywords: apoptosis; cancer; Tp53; Tp63; Tp73; ubiquitination; E3 ligase 1. Introduction The “guardian of the genome”, p53, has long been known to regulate the cellular responses of DNA repair, cell senescence, cell cycle arrest, and apoptosis [1]. Mice deficient in p53 exhibit significantly increased susceptibility to tumor formation compared to wild type mice and are a valuable tool with which to study the effects of p53 on tumor initiation and progression [2].
    [Show full text]
  • HPV Oncoproteins and the Ubiquitin Proteasome System: a Signature of Malignancy?
    pathogens Review HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy? 1, 1, 2 1 Anamaria Đuki´c y, Lucija Luli´c y, Miranda Thomas , Josipa Skelin , Nathaniel Edward Bennett Saidu 1 , Magdalena Grce 1, Lawrence Banks 2 and Vjekoslav Tomai´c 1,* 1 Division of Molecular Medicine, Ruđer Boškovi´cInstitute, Bijeniˇckacesta 54, 10000 Zagreb, Croatia; [email protected] (A.Ð.); [email protected] (L.L.); [email protected] (J.S.); [email protected] (N.E.B.S.); [email protected] (M.G.) 2 International Centre for Genetic Engineering and Biotechnology, AREA Science Park, Padriciano 99, I-34149 Trieste, Italy; [email protected] (M.T.); [email protected] (L.B.) * Correspondence: [email protected]; Tel.: +385-1-4561110; Fax: +385-1-4561010 These authors contributed equally to this work. y Received: 20 December 2019; Accepted: 11 February 2020; Published: 18 February 2020 Abstract: Human papillomavirus (HPV) E6 and E7 oncoproteins are critical for development and maintenance of the malignant phenotype in HPV-induced cancers. These two viral oncoproteins interfere with a plethora of cellular pathways, including the regulation of cell cycle and the control of apoptosis, which are critical in maintaining normal cellular functions. E6 and E7 bind directly with certain components of the Ubiquitin Proteasome System (UPS), enabling them to manipulate a number of important cellular pathways. These activities are the means by which HPV establishes an environment supporting the normal viral life cycle, however in some instances they can also lead to the development of malignancy. In this review, we have discussed how E6 and E7 oncoproteins from alpha and beta HPV types interact with the components of the UPS, and how this interplay contributes to the development of cancer.
    [Show full text]
  • Comprehensive Genomic Survey, Characterization and Expression Analysis of the HECT Gene Family in Brassica Rapa L
    G C A T T A C G G C A T genes Article Comprehensive Genomic Survey, Characterization and Expression Analysis of the HECT Gene Family in Brassica rapa L. and Brassica oleracea L. Intikhab Alam 1, Dong-Li Cui 1, Khadija Batool 2, Yan-Qing Yang 1 and Yun-Hai Lu 1,* 1 Key Laboratory of Ministry of Education for Genetics, Breeding and Multiple Utilization of Crops, College of Crop Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China; [email protected] (I.A.); [email protected] (D.-L.C.); [email protected] (Y.-Q.Y.) 2 State Key Laboratory of Ecological Pest Control for Fujian and Taiwan Crops, College of Life Sciences, Key Lab of Biopesticides and Chemical Biology, Fujian Agriculture and Forestry University, Fuzhou 350002, China; [email protected] * Correspondence: [email protected] or [email protected] Received: 23 March 2019; Accepted: 13 May 2019; Published: 27 May 2019 Abstract: The HECT-domain protein family is one of the most important classes of E3 ligases. While the roles of this family in human diseases have been intensively studied, the information for plant HECTs is limited. In the present study, we performed the identification of HECT genes in Brassica rapa and Brassica oleracea, followed by analysis of phylogeny, gene structure, additional domains, putative cis-regulatory elements, chromosomal location, synteny, and expression. Ten and 13 HECT genes were respectively identified in B. rapa and B. oleracea and then resolved into seven groups along with their Arabidopsis orthologs by phylogenetic analysis. This classification is well supported by analyses of gene structure, motif composition within the HECT domain and additional protein domains.
    [Show full text]